Reaction

Pulse Abnormal reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,389 reports · 35 co-occurring drugs

As of the last recalculation, Pulse Abnormal appears in 2,389 FAERS reports alongside 35 co-occurring drug terms. The strongest observed disproportionality signal is IOHEXOL (PRR 20.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Iohexol1920.120.2
Iron Sucrose1715.615.7
Octreotide Acetate4212.112.2
Telmisartan2210.810.8
Atomoxetine Hydrochloride259.29.2
Sitagliptin And Metformin Hydrochloride229.09.0
Selexipag268.98.9
Lisdexamfetamine Dimesylate338.88.8
Lithium238.08.0
Lithium Bromatum238.08.0
Methoxy Polyethylene Glycol-Epoetin Beta107.97.9
Timolol Maleate87.17.1
Liothyronine Sodium77.07.0
Abaloparatide236.96.9
Clonidine376.46.4
Lanreotide Acetate55.65.6
Amlodipine Besylate And Valsartan75.55.5
Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate And Amphetamine Aspartate255.35.3
Dronedarone65.15.1
Fosaprepitant Dimeglumine85.15.1
Clobazam145.05.0
Droxidopa114.54.5
Apixaban334.34.3
Insulin Degludec103.73.7
Encorafenib43.53.5
Pembrolizumab423.53.5
Dofetilide43.33.3
Sacubitril And Valsartan433.33.3
Umeclidinium Bromide And Vilanterol Trifenatate63.13.1
Cetuximab102.82.8
Axitinib62.72.7
Ambrisentan292.02.0
Esketamine Hydrochloride31.51.5
Erenumab-Aooe91.41.4
Evolocumab181.01.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.